Cormedix Inc (NAS:CRMD)
$ 8.405 0.075 (0.9%) Market Cap: 505.44 Mil Enterprise Value: 459.97 Mil PE Ratio: 0 PB Ratio: 8.25 GF Score: 35/100

Q1 2022 CorMedix Inc Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Release Date Price: $2.98 (-1.97%)
Operator

Hello, and welcome to the CorMedix Inc. First Quarter 2022 Earnings Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Daniel Ferry with LifeSci Advisors. Please go ahead.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Good afternoon, and welcome to the CorMedix First Quarter 2022 Earnings Conference Call. Leading the call today is Joe Todisco, newly appointed Chief Executive Officer of CorMedix; and Dr. Matt David, Executive Vice President and CFO. They are joined by Dr. Phoebe Mounts, EVP, General Counsel and Head of Technical Operations; and Erin Mistry, SVP and Head of Payer Strategy, Government Affairs and Trade.

Before we begin, I would like to remind everyone that during the call, Management may make what are known as forward-looking statements within the meaning set forth in the Private Securities Litigation Reform Act of 1995. These statements are subject to certain risks and uncertainties and include, but are not limited to, any of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot